Dongxin Lin

26PUBLICATIONS
67CO-AUTHORS
Molecular targetsCancer cell biologyMajor global burdens of diseasePredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 23, 2026
Mutant TP53 hijacks RNA-splicing factor RBM28 to suppress double-stranded RNA triggered antitumor immunity.

|Jul 23, 2026
Krüppel-like factor 4 downregulation during esophageal cancer formation facilitates immune evasion and impairs immunotherapy.

|May 06, 2026
CKS1B is a tumor-intrinsic factor driving CD8+ T cell exhaustion via maintaining persistent tumor-antigen stimulation.

|Apr 15, 2026
Esophageal cancer: from pathogenesis to precision therapies.

|Mar 09, 2026
Ectopic CD11c Drives SMAD3-Mediated Aberrant Antigen Presentation and Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma.

Han Liao, Xuan Zhao, Liping Chen

|Feb 26, 2026
A Circulating GPNMB-Based Multimodal Model Integrates Tumor-Immune Crosstalk to Predict Immunotherapy Response in Esophageal Cancer.

Liang Zhu, Xiaoyuan Wang, Guoyu Cheng

Pageof 5

Frequent Collaborators

10 joint publications

Chen Wu

7 joint publications

Shaosen Zhang

7 joint publications

Jian Zheng

6 joint publications

Lingxing Zeng